Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of the genome to personalize therapy for melanoma.
Davies MA, Samuels Y. Davies MA, et al. Among authors: samuels y. Oncogene. 2010 Oct 14;29(41):5545-55. doi: 10.1038/onc.2010.323. Epub 2010 Aug 9. Oncogene. 2010. PMID: 20697348 Free PMC article. Review.
Topical therapy for regression and melanoma prevention of congenital giant nevi.
Choi YS, Erlich TH, von Franque M, Rachmin I, Flesher JL, Schiferle EB, Zhang Y, Pereira da Silva M, Jiang A, Dobry AS, Su M, Germana S, Lacher S, Freund O, Feder E, Cortez JL, Ryu S, Babila Propp T, Samuels YL, Zakka LR, Azin M, Burd CE, Sharpless NE, Liu XS, Meyer C, Austen WG Jr, Bojovic B, Cetrulo CL Jr, Mihm MC, Hoon DS, Demehri S, Hawryluk EB, Fisher DE. Choi YS, et al. Among authors: samuels yl. Cell. 2022 Jun 9;185(12):2071-2085.e12. doi: 10.1016/j.cell.2022.04.025. Epub 2022 May 12. Cell. 2022. PMID: 35561684 Free PMC article.
Temporal genomic analysis of homogeneous tumor models reveals key regulators of immune evasion in melanoma.
Cohen Shvefel S, Pai JA, Cao Y, Pal LR, Bartok O, Levy R, Zemanek MJ, Weller C, Herzog E, Yao W, Hiam-Galvez KJ, Cheng K, Yin Y, Du PP, Raposo CJ, Gumpert N, Welti M, Martínez Gómez JM, Sella F, Yakubovich E, Orr I, Ben-Dor S, Oren R, Fellus-Alyagor L, Golani O, Brenner OJ, Salame TM, Zerbib M, Goliand I, Ranmar D, Savchenko I, Ketrarou N, Schaffer AA, Dahan R, Levesque MP, Ruppin E, Satpathy AT, Samuels Y. Cohen Shvefel S, et al. Among authors: samuels y. Cancer Discov. 2024 Nov 20. doi: 10.1158/2159-8290.CD-23-1422. Online ahead of print. Cancer Discov. 2024. PMID: 39715301
A modular protein language modelling approach to immunogenicity prediction.
O'Brien H, Salm M, Morton LT, Szukszto M, O'Farrell F, Boulton C, King L, Bola SK, Becker PD, Craig A, Nielsen M, Samuels Y, Swanton C, Mansour MR, Hadrup SR, Quezada SA. O'Brien H, et al. Among authors: samuels y. PLoS Comput Biol. 2024 Nov 11;20(11):e1012511. doi: 10.1371/journal.pcbi.1012511. eCollection 2024 Nov. PLoS Comput Biol. 2024. PMID: 39527593 Free PMC article.
Breaking the performance ceiling for neoantigen immunogenicity prediction.
O'Brien H, Salm M, Morton LT, Szukszto M, O'Farrell F, Boulton C, Becker PD, Samuels Y, Swanton C, Mansour MR, Reker Hadrup S, Quezada SA. O'Brien H, et al. Among authors: samuels y. Nat Cancer. 2023 Dec;4(12):1618-1621. doi: 10.1038/s43018-023-00675-z. Nat Cancer. 2023. PMID: 38102360 No abstract available.
Temporal genomic analysis of melanoma rejection identifies regulators of tumor immune evasion.
Cohen Shvefel S, Pai JA, Cao Y, Pal LR, Levy R, Yao W, Cheng K, Zemanek M, Bartok O, Weller C, Yin Y, Du PP, Yakubovich E, Orr I, Ben-Dor S, Oren R, Fellus-Alyagor L, Golani O, Goliand I, Ranmar D, Savchenko I, Ketrarou N, Schäffer AA, Ruppin E, Satpathy AT, Samuels Y. Cohen Shvefel S, et al. Among authors: samuels y. bioRxiv [Preprint]. 2023 Nov 29:2023.11.29.569032. doi: 10.1101/2023.11.29.569032. bioRxiv. 2023. PMID: 38077050 Free PMC article. Preprint.
The landscape of T cell antigens for cancer immunotherapy.
Peri A, Salomon N, Wolf Y, Kreiter S, Diken M, Samuels Y. Peri A, et al. Among authors: samuels y. Nat Cancer. 2023 Jul;4(7):937-954. doi: 10.1038/s43018-023-00588-x. Epub 2023 Jul 6. Nat Cancer. 2023. PMID: 37415076 Review.
The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC.
Javitt A, Shmueli MD, Kramer MP, Kolodziejczyk AA, Cohen IJ, Radomir L, Sheban D, Kamer I, Litchfield K, Bab-Dinitz E, Zadok O, Neiens V, Ulman A, Wolf-Levy H, Eisenberg-Lerner A, Kacen A, Alon M, Rêgo AT, Stacher-Priehse E, Lindner M, Koch I, Bar J, Swanton C, Samuels Y, Levin Y, da Fonseca PCA, Elinav E, Friedman N, Meiners S, Merbl Y. Javitt A, et al. Among authors: samuels y. Nat Cancer. 2023 May;4(5):629-647. doi: 10.1038/s43018-023-00557-4. Epub 2023 May 22. Nat Cancer. 2023. PMID: 37217651
Large-Scale Immunopeptidome Analysis Reveals Recurrent Posttranslational Splicing of Cancer- and Immune-Associated Genes.
Levy R, Alter Regev T, Paes W, Gumpert N, Cohen Shvefel S, Bartok O, Dayan-Rubinov M, Alon M, Shmueli MD, Levin Y, Merbl Y, Ternette N, Samuels Y. Levy R, et al. Among authors: samuels y. Mol Cell Proteomics. 2023 Apr;22(4):100519. doi: 10.1016/j.mcpro.2023.100519. Epub 2023 Feb 23. Mol Cell Proteomics. 2023. PMID: 36828127 Free PMC article.
109 results